Beacon Therapeutics
Transforming Vision, Transforming Lives
95 employees · est. 2023 · London, United Kingdom
VIAN Therapeutics
Protecting sight with a simple eye drop.
4 employees · est. 2023 · San Francisco, United States
Beacon Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Beacon Therapeutics | VIAN Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2023 |
| Headquarters | ||
| Headquarters | London, United Kingdom | San Francisco, United States |
| Employees | ||
| Employees | 95 larger | 4 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Seed |
| Total Funding | ||
| Total Funding | $341.00M | $275.00K |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Not tracked yet | Development of non-invasive eye drops, Therapeutic solutions for retinal diseases, Research in angiogenesis and inflammation, Biotech strategy consulting |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with AMD and DME, Ophthalmologists, Healthcare providers in ophthalmology, Biotech and pharmaceutical companies |
| Taxonomy | ||
| Taxonomy | Ophthalmic Gene Therapy, Retinal Diseases, X-linked Retinitis Pigmentosa, AMD (age-related Macular Degeneration), Cone-rod Dystrophy, Gene Therapy Program, RPGR Gene, Clinical Trials, Target Generation Technology, Syncona, Oxford Science Enterprises, Inherited Retinal Diseases, Vision Restoration, Blindness | Microvascular Retinal Diseases, Diabetic Retinopathy, Age-related Macular Degeneration, Cyclic Peptide Drugs, Eyedrop Administration, Retinal Blood Vessels Stabilization, Non-invasive Ocular Treatment, Ocular Care Innovation, Retinal Health, Angiogenesis Inhibitors, Antiangiogenic Therapy, Diabetic Macular Edema, Virtual Pharmaceutical Startup, Ophthalmic Drug Development, Vision Protection |
| Website | ||
| Website | beacontx.com | viantx.com |
About Beacon Therapeutics
Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases leading to blindness. The company's scientific foundation encompasses a late-stage development candidate...
About VIAN Therapeutics
VIAN Therapeutics is a promising player in the biotechnology and pharmaceutical industries, making a significant impact since its founding in 2023. Headquartered in the United States, the company is committed to addressing the global challenge of microvascular retinal diseases like diabetic retinopa...
We will tell you when either one moves
BounceWatch watches Beacon Therapeutics and VIAN Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Beacon Therapeutics and VIAN Therapeutics — by email.
Frequently Asked Questions
Compare Beacon Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Beacon Therapeutics on 9 Jun 2026, and VIAN Therapeutics on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
